| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/18/2007 | CN100998622A Traditional Chinese medicine preparations for treating cardiovascular and cerebrovascular diseases the preparation method and use thereof |
| 07/18/2007 | CN100998617A Quality control method for Xindakang preparation |
| 07/18/2007 | CN100998592A Microemulsion containing matrine |
| 07/18/2007 | CN100998565A Anti-angiogene compositions and methods of use |
| 07/17/2007 | US7244833 Yeast expressed with cell proliferation stimulatory factor; hematological disorders |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244426 Pharmaceutical compositions of fibrinolytic agent |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2285542C N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 07/17/2007 | CA2283198C Butyrate prodrugs derived from lactic acid |
| 07/17/2007 | CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4 |
| 07/17/2007 | CA2132887C Tricyclic 1-aminoethylpyrrole-derivatives |
| 07/12/2007 | WO2007078202A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 07/12/2007 | WO2007077990A1 Drug delivery material |
| 07/12/2007 | WO2003077723A3 Methods and devices for detection and therapy of atheromatous plaque |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161643 Pyridin-2-one compounds useful as inhibitors of thrombin |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | US20070161557 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070161073 Methods and products related to evaluating the quality of a polysaccharide |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | CA2636265A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 07/11/2007 | EP1806357A1 Hypoxia inducible factor-1 and method of use |
| 07/11/2007 | EP1806356A2 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 07/11/2007 | EP1805176A2 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 07/11/2007 | EP1805155A1 Thrombopoietin activity modulating compounds and methods |
| 07/11/2007 | EP1804780A1 Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 07/11/2007 | EP1608646B1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 07/11/2007 | EP1248784B1 Condensed azepines as vasopressin agonists |
| 07/11/2007 | EP1204414B1 Use of morphinan derivates as medicines |
| 07/11/2007 | CN1997647A Clopidogrel salt and polymorphic forms thereof |
| 07/11/2007 | CN1997385A Annexin V for preventing atherothrombois and plaque rupture |
| 07/11/2007 | CN1997358A The use of kauranes compounds in the preparation of medicament |
| 07/11/2007 | CN1995068A Angelica polysaccharide iron and its preparing process |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1994398A Chinese medicinal formulation for treating polycythaemia, preparation process and quality control method thereof |
| 07/11/2007 | CN1994366A Chinese medicinal formulation for treating gynecological disease and preparation process thereof |
| 07/11/2007 | CN1994351A Yeradetajo extract, its preparation method and use |
| 07/11/2007 | CN1994316A Hydroxyethyl starch injection liquid and preparation method thereof |
| 07/11/2007 | CN1994261A Application of L-2-oxathiaazalane-4-carboxylic acid and ester derivative thereof in cosmeceutical product |
| 07/11/2007 | CN1994155A Healthy oral liquid and preparation method thereof |
| 07/11/2007 | CN1994148A Health beverage made from Codonopsis lanceolata Benth .et Hook. |
| 07/11/2007 | CN1325639C Preparation method for high purity lumbrukinase and pharmaceutical preparation made therefrom |
| 07/11/2007 | CN1325116C Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer |
| 07/11/2007 | CN1325070C Chinese traditional medicine Tripterygium wilfordii and improving technique for attenuation and synergy of its extract |
| 07/11/2007 | CN1325061C Plasma preparation or serum preparation and process for producing the same |
| 07/11/2007 | CN1325051C Compound medicine of ozagrel and its salt and troxerutin |
| 07/11/2007 | CN1325046C Biodegradable polymeric nanocapsules and uses thereof |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241783 Using a thiosemicarbazone |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241766 Methods of using phenolic guanidine sodium channel blockers |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241757 Amidino derivatives and their use as thrombin inhibitors |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241571 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2199401C Pyrimido[5,4-d]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 07/10/2007 | CA2064604C Method for inhibiting pulmonary oxygen toxicity |
| 07/05/2007 | WO2007076431A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/05/2007 | WO2007075115A1 Hemostatic agent |
| 07/05/2007 | WO2007075017A1 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid |
| 07/05/2007 | WO2007074995A1 Process for the preparation of s-(+)-clopidogrel by optical resolution |
| 07/05/2007 | WO2007013123A8 Cyclodextrins for blood detoxification |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155719 Platelet ADP receptor inhibitors |
| 07/05/2007 | US20070155703 Pharmaceutically active compounds and methods of use thereof |
| 07/05/2007 | US20070154918 44 Human Secreted Proteins |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | DE20122736U1 Beschichteter Ballonkatheter Coated balloon catheter |
| 07/05/2007 | CA2635255A1 Process for the preparation of s-(+)-clopidogrel by optical resolution |
| 07/05/2007 | CA2634907A1 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 07/05/2007 | CA2634794A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/04/2007 | EP1803810A1 Integrin antagonists |
| 07/04/2007 | EP1803808A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803719A1 1,5-diheterocycle-1h-triazole derivative |
| 07/04/2007 | EP1802609A2 Thrombin receptor antagonists |
| 07/04/2007 | EP1802280A2 Clopidogrel compositions |
| 07/04/2007 | EP1397128B1 Kappa opoid agonist for the treatment of irritable bladder |
| 07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |
| 07/04/2007 | EP1124982B1 THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i |
| 07/04/2007 | EP1054594B1 Inotropic and diuretic effects of exendin and glp-1 |
| 07/04/2007 | EP0994716B2 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |